These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 3523374)
1. [Plasma thromboxane and prostacyclin metabolite ratio in atherosclerosis and diabetic angiopathy]. Udvardy M; Török I; Misz M; Boda Z; Tornai I; Pfliegler G; Rák K Orv Hetil; 1986 Jun; 127(22):1307-10. PubMed ID: 3523374 [No Abstract] [Full Text] [Related]
2. [The content of stable forms of prostacyclin I2 and thromboxane A2 in the blood plasma in diabetic angiopathies]. Sergienko AA Probl Endokrinol (Mosk); 1991; 37(4):24-6. PubMed ID: 1788186 [TBL] [Abstract][Full Text] [Related]
3. [Connection between plasma thromboxane and prostacyclin levels in the metabolic control of diabetic children]. Orosz L; Udvardy M; Vincze P; Fehér A; Madácsy L Orv Hetil; 1989 Jan; 130(3):125-8. PubMed ID: 2643785 [TBL] [Abstract][Full Text] [Related]
4. [Experimental study of atherosclerosis. II. The effect of 8501 on the balance between thromboxane A2 and prostacyclin in preventing experimental atherosclerosis of rabbits]. Wang Z Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Dec; 10(6):421-5. PubMed ID: 2978398 [No Abstract] [Full Text] [Related]
5. [Significance of eicosanoids for arteriosclerosis and the effect of lipoproteins on prostanoid formation]. Mest HJ; Beitz J Z Gesamte Inn Med; 1986 Feb; 41(4):94-8. PubMed ID: 3518258 [TBL] [Abstract][Full Text] [Related]
6. Plasma thromboxane and prostacyclin metabolite ratio in atherosclerosis and diabetes mellitus. Udvardy M; Török I; Rak K Thromb Res; 1987 Aug; 47(4):479-84. PubMed ID: 3116717 [TBL] [Abstract][Full Text] [Related]
7. [Status of the prostacyclin-thromboxane A2 system in patients with ischemic heart disease during induced myocardial ischemia]. Nikolaeva LF; Aleshin OI; Pavlov NA; Pomerantsev EV; Masenko VP Sov Med; 1988; (4):3-6. PubMed ID: 3043710 [No Abstract] [Full Text] [Related]
8. Effect of sodium selenite supplementation on the levels of prostacyclin I(2) and thromboxane A(2) in human. Abdulah R; Katsuya Y; Kobayashi K; Nakazawa M; Nara M; Murakami M; Koyama H Thromb Res; 2007; 119(3):305-10. PubMed ID: 16564072 [No Abstract] [Full Text] [Related]
9. [The role of thromboxane A2 and prostacyclin in the pathogenesis of diabetes mellitus in children and adolescents]. Vakhrusheva LL; Kniazev IuA; Martynova MI; Pirogova LB Pediatriia; 1991; (2):18-22. PubMed ID: 2057285 [TBL] [Abstract][Full Text] [Related]
10. Dihomo-gamma-linolenic acid in patients with atherosclerosis: effects on platelet aggregation, plasma lipids and low-density lipoprotein-induced inhibition of prostacyclin generation. Szczeklik A; Gryglewski RJ; Sladek K; Kostaka-Trabka E; Zmuda A Thromb Haemost; 1984 Apr; 51(2):186-8. PubMed ID: 6377563 [TBL] [Abstract][Full Text] [Related]
11. Lipid peroxides, prostacyclin, and thromboxane A2 in runners during acute exercise. Viinikka L; Vuori J; Ylikorkala O Med Sci Sports Exerc; 1984 Jun; 16(3):275-7. PubMed ID: 6379367 [TBL] [Abstract][Full Text] [Related]
12. [Effect of aspirin combined with perindopril on prostacyclin, thromboxone A2, and norepinephrine in the blood of arteriosclerosis rabbit models and the cardiac function]. Zhuang HP; Li J; Liu LH Hunan Yi Ke Da Xue Xue Bao; 2003 Feb; 28(1):37-40. PubMed ID: 12934393 [TBL] [Abstract][Full Text] [Related]
13. [Changes of thromboxane A2 and prostacyclin in the pregnant hypertensive syndrome]. Shen XY Zhonghua Yi Xue Za Zhi; 1984 Dec; 64(12):735-7, 790. PubMed ID: 6443193 [No Abstract] [Full Text] [Related]
14. [The role of prostacycline, thromboxane A2 and prostaglandins in platelet aggregation (author's transl)]. Herman AG Rev Med Brux; 1981 Mar; 2(3):251-7. PubMed ID: 7015444 [No Abstract] [Full Text] [Related]
15. Effect of cytostatics on prostaglandin F2 alpha prostacyclin, and thromboxane in patients with gynecologic malignancies. Ylikorkala O; Kauppila A; Viinikka L Obstet Gynecol; 1981 Oct; 58(4):483-6. PubMed ID: 7024882 [TBL] [Abstract][Full Text] [Related]
17. [Thromboxane A2 and prostacyclin in patients with chronic glomerulonephritis and coronary heart disease in contrast media nephrotoxicity. Protective effects of calcium antagonists]. Dzgoeva FU; Kutyrina IM Ter Arkh; 2000; 72(6):42-5. PubMed ID: 10900648 [TBL] [Abstract][Full Text] [Related]
18. [The prostacyclin-thromboxane system and bronchial patency in patients with pulmonary tuberculosis]. Petrenko VI Lik Sprava; 1996; (3-4):69-71. PubMed ID: 9035887 [TBL] [Abstract][Full Text] [Related]
19. Des-amino-D-arginine vasopressin does not increase circulating levels of prostacyclin or thromboxane A2 during infusion in man. Barrow SE; Heavey DJ; Jacqz E; Blair IA; Dollery CT Thromb Haemost; 1983 Aug; 50(2):622. PubMed ID: 6356457 [No Abstract] [Full Text] [Related]
20. An imbalance between the excretion of thromboxane and prostacyclin metabolites in women after the menopause. Jendryczko A; Tomala J Zentralbl Gynakol; 1993; 115(4):163-6. PubMed ID: 8503234 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]